1. Home
  2. INFU vs NHS Comparison

INFU vs NHS Comparison

Compare INFU & NHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INFU
  • NHS
  • Stock Information
  • Founded
  • INFU 2005
  • NHS 2003
  • Country
  • INFU United States
  • NHS United States
  • Employees
  • INFU N/A
  • NHS N/A
  • Industry
  • INFU Medical/Dental Instruments
  • NHS Trusts Except Educational Religious and Charitable
  • Sector
  • INFU Health Care
  • NHS Finance
  • Exchange
  • INFU Nasdaq
  • NHS Nasdaq
  • Market Cap
  • INFU 211.6M
  • NHS 226.7M
  • IPO Year
  • INFU N/A
  • NHS N/A
  • Fundamental
  • Price
  • INFU $9.42
  • NHS $7.15
  • Analyst Decision
  • INFU Strong Buy
  • NHS
  • Analyst Count
  • INFU 2
  • NHS 0
  • Target Price
  • INFU $14.50
  • NHS N/A
  • AVG Volume (30 Days)
  • INFU 197.4K
  • NHS 111.8K
  • Earning Date
  • INFU 11-04-2025
  • NHS 01-01-0001
  • Dividend Yield
  • INFU N/A
  • NHS 13.44%
  • EPS Growth
  • INFU 271.43
  • NHS N/A
  • EPS
  • INFU 0.26
  • NHS N/A
  • Revenue
  • INFU $141,054,000.00
  • NHS N/A
  • Revenue This Year
  • INFU $9.02
  • NHS N/A
  • Revenue Next Year
  • INFU $6.73
  • NHS N/A
  • P/E Ratio
  • INFU $36.47
  • NHS N/A
  • Revenue Growth
  • INFU 6.23
  • NHS N/A
  • 52 Week Low
  • INFU $4.61
  • NHS $6.95
  • 52 Week High
  • INFU $11.04
  • NHS $9.17
  • Technical
  • Relative Strength Index (RSI)
  • INFU 45.22
  • NHS 38.28
  • Support Level
  • INFU $9.12
  • NHS $7.04
  • Resistance Level
  • INFU $9.72
  • NHS $7.27
  • Average True Range (ATR)
  • INFU 0.50
  • NHS 0.09
  • MACD
  • INFU -0.08
  • NHS -0.03
  • Stochastic Oscillator
  • INFU 22.61
  • NHS 24.85

About INFU InfuSystems Holdings Inc.

InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.

About NHS Neuberger Berman High Yield Strategies Fund

Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.

Share on Social Networks: